News of Note—Indian vaccine controversy, Genocea and more

newspapers
In this week's news of note, Genocea named two new executives. (Pixabay)

Here is some other vaccine news of note for the week:

> Officials in India inadvertently distributed a batch of tainted polio vaccines, but the WHO said the risk of infection for children was "minimal." Reuters article

> Genocea appointed Thomas Davis as its chief medical officer and Derek Meisner as its general counsel. Release

Free Amazon Webinar

Performing end to end real-world evidence generation in the cloud with traceability and transparency- a Sanofi journey

In this webinar you will hear about Sanofi’s journey and experience in building an industrialized big data & analytics platform in the cloud that handles billions of rows of RWD data with complete data traceability, security, and supports both traditional and advanced analytics for day to day evidence generation (RWE).

> OncBioMune kicked off a phase 2 trial of a candidate vaccine to treat prostate cancer. Release

> BlueWIllow Biologics picked up a Small Business Innovation Research grant from the National Institutes of Health to work on a chlamydia vaccine. Release

Suggested Articles

Amid the COVID-19 pandemic, many teams of researchers are working on potential vaccines. We asked experts to assess progress—and point out challenges.

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

Pfizer posted positive top-line results for a trial of its 20-valent pneumococcal vaccine, potentially setting up a filing by the end of 2020.